We analyzed whole genomes of unique paired samples from smoldering multiple myeloma (SMM) patients progressing to multiple myeloma (MM). We report that the genomic landscape, including mutational profile and structural rearrangements at the smoldering stage is very similar to MM. Paired sample analysis shows two different patterns of progression: a "static progression model", where the subclonal architecture is retained as the disease progressed to MM suggesting that progression solely reflects the time needed to accumulate a sufficient disease burden; and a "spontaneous evolution model", where a change in the subclonal composition is observed. We also observe that activation-induced cytidine deaminase plays a major role in shaping the mutational landscape of early subclinical phases, while progression is driven by APOBEC cytidine deaminases. These results provide a unique insight into myelomagenesis with potential implications for the definition of smoldering disease and timing of treatment initiation.

Genomic patterns of progression in smoldering multiple myeloma / N. Bolli, F. Maura, S. Minvielle, D. Gloznik, R. Szalat, A. Fullam, I. Martincorena, K.J. Dawson, M.K. Samur, J. Zamora, P. Tarpey, H. Davies, M. Fulciniti, M.A. Shammas, Y.T. Tai, F. Magrangeas, P. Moreau, P. Corradini, K. Anderson, L. Alexandrov, D.C. Wedge, H. Avet-Loiseau, P. Campbell, N. Munshi. - In: NATURE COMMUNICATIONS. - ISSN 2041-1723. - 9:1(2018 Dec). [10.1038/s41467-018-05058-y]

Genomic patterns of progression in smoldering multiple myeloma

N. Bolli
Primo
;
F. Maura;P. Corradini;
2018

Abstract

We analyzed whole genomes of unique paired samples from smoldering multiple myeloma (SMM) patients progressing to multiple myeloma (MM). We report that the genomic landscape, including mutational profile and structural rearrangements at the smoldering stage is very similar to MM. Paired sample analysis shows two different patterns of progression: a "static progression model", where the subclonal architecture is retained as the disease progressed to MM suggesting that progression solely reflects the time needed to accumulate a sufficient disease burden; and a "spontaneous evolution model", where a change in the subclonal composition is observed. We also observe that activation-induced cytidine deaminase plays a major role in shaping the mutational landscape of early subclinical phases, while progression is driven by APOBEC cytidine deaminases. These results provide a unique insight into myelomagenesis with potential implications for the definition of smoldering disease and timing of treatment initiation.
Settore MED/15 - Malattie del Sangue
dic-2018
22-ago-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
1E113886-904E-401A-9380-86DE938DBF1F.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.76 MB
Formato Adobe PDF
1.76 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/585912
Citazioni
  • ???jsp.display-item.citation.pmc??? 91
  • Scopus 145
  • ???jsp.display-item.citation.isi??? 141
social impact